A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer

INTRODUCTION: Radium-223, abiraterone, and enzalutamide have each been shown to significantly improve survival as monotherapy in patients with metastatic castration-resistant prostate cancer. However, effects of combination radium-223 plus abiraterone or enzalutamide on survival and safety remain un...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PLoS One
Hlavní autoři: Kim, Stephanie I., Szeto, Andy H., Morgan, Katherine P., Brower, Blaine, Dunn, Mary W., Khandani, Amir H., Godley, Paul A., Rose, Tracy L., Basch, Ethan M., Milowsky, Matthew I., Whang, Young E., Crona, Daniel J.
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2021
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8216516/
https://ncbi.nlm.nih.gov/pubmed/34153052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0253021
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky